Screener
LeonaBio, Inc. LONA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by LeonaBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: LeonaBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211898
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (17,214) | (9,536) |
| Other income, net | 586 | 393 |
| Sermonix pre-funded warrant change in fair value | (16,320) | — |
| Net loss | $(32,948) | $(9,143) |
| Unrealized (loss) gain on available-for-sale securities | (9) | (5) |
| Comprehensive loss attributable to common stockholders | $(32,957) | $(9,148) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.73) | $(2.34) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (1) | 19,027,087 | 3,904,244 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is LeonaBio, Inc.'s net income?
- LeonaBio, Inc. (LONA) reported net income of -$32.95M in Q1 2026.
- How has LeonaBio, Inc.'s net income changed year-over-year?
- LeonaBio, Inc.'s net income decreased by 260.4% year-over-year, from -$9.14M to -$32.95M.
- What is the long-term trend for LeonaBio, Inc.'s net income?
- Over 4 years (2021 to 2025), LeonaBio, Inc.'s net income has grown at a 17.8% compound annual growth rate (CAGR), from -$54.85M to -$105.61M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about LeonaBio, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude